Director, Medical Science Liaison (West) - Molecular Residual Disease

SAGA Diagnostics is a personalized cancer diagnostics and disease monitoring company focused on molecular genetic analysis of circulating tumor DNA (ctDNA). The company's mission is to improve precision cancer medicine, provide more accurate treatment monitoring, and improve patient survival using minimally invasive liquid biopsy cancer testing services. SAGA's proprietary tests can help patients, oncologists, and drug developers detect actionable mutations, stratify patient groups, and monitor treatment response, residual disease, and disease recurrence at unprecedented sensitivity and scale.

We are seeking an experienced and dynamic Medical Science Liaison (MSL) to lead and support our West Regional team. This individual will be responsible for both strategic leadership and direct field engagement, ensuring scientific excellence in the dissemination and application of MRD knowledge across key opinion leaders (KOLs), clinical stakeholders, and cross-functional partners. The successful candidate will serve as a senior scientific ambassador for SAGA’s molecular diagnostics portfolio, playing a critical role in shaping the clinical adoption and implementation of MRD testing in oncology.

Key Responsibilities:

1. Scientific Expertise and Communication:
• Act as the primary scientific resource and subject matter expert for molecular residual disease testing, its clinical utility, and application in oncology.
• Communicate and disseminate cutting-edge scientific information regarding MRD testing methods (e.g., PCR, NGS, flow cytometry) and their role in patient management, recurrence detection, and treatment decision-making.
• Provide scientific support to healthcare professionals, researchers, and clinical teams regarding the latest MRD-related research, product development, and applications in oncology.
2. KOL Engagement and Relationship Building:
• Identify, engage, and establish relationships with key opinion leaders (KOLs), oncologists, hematologists, and other stakeholders involved in MRD research and clinical practice.
• Present scientific data, research findings, and clinical evidence related to MRD assays to KOLs, driving discussions on the clinical utility of MRD testing in various cancer types.
• Coordinate advisory boards, scientific symposia, and research collaborations with KOLs to foster ongoing dialogue and knowledge sharing.
3. Clinical and Scientific Support:
• Provide insights to internal teams (e.g., product development, regulatory, marketing, sales) regarding MRD-related scientific data, clinical studies, and market needs.
• Interpret clinical trial data, real-world evidence, and research studies related to MRD and contribute to discussions around its clinical impact, including in early- and late-stage cancer care.
• Support the design of clinical studies and post-market surveillance to evaluate the effectiveness and application of MRD testing in different oncologic settings.
4. Training and Education:
• Deliver scientific presentations, educational workshops, and training sessions to internal teams, healthcare providers, and clinical partners on MRD testing and its role in cancer monitoring and treatment.
• Ensure that medical and sales teams are equipped with comprehensive, up-to-date knowledge on MRD assays, including their clinical benefits and limitations.
• Develop and review educational materials, including scientific publications, product briefs, and clinical guides, to enhance awareness and adoption of MRD testing.
5. Scientific Data Generation and Dissemination:
• Collaborate with research and clinical teams to design and implement studies that generate data to support the clinical value of MRD testing, including clinical trials, retrospective studies, and registries.
• Work with cross-functional teams to develop scientific content for publication in peer-reviewed journals, presentation at scientific conferences, and development of abstracts and posters.
• Contribute to the creation of evidence-based materials such as white papers, case studies, and real-world data to demonstrate the clinical relevance of MRD testing in cancer management.
6. Market Intelligence:
• Monitor the evolving landscape of MRD testing, including new technologies, competitor products, clinical advancements, and regulatory changes.
• Stay informed on emerging trends in oncology and MRD-related research, particularly in areas like liquid biopsy, immuno-oncology, and companion diagnostics.
• Provide feedback and market insights to the product development and strategy teams to inform the company’s MRD-related product portfolio and future opportunities.
7. Regulatory and Compliance:
• Ensure that all scientific activities and interactions with he